7-T MR-from research to clinical applications?

NMR in Biomedicine

Volumn 25, Issue 5, 2012, Pages 695-716

  Moser, Ewald ^a,b   Stahlberg, Freddy ^c   Ladd, Mark E ^d   Trattnig, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

7T; Brain; Cartilage; Heart; Safety; Skeletal muscle; Ultrahigh field MR; Vascular

Indexed keywords

7T; BRAIN IMAGING; CLINICAL APPLICATION; CLINICAL DIAGNOSIS; CLINICAL DIAGNOSTIC IMAGING; CURRENT STATUS; FUNCTIONAL IMAGING; FUNCTIONAL MRI; HIGH RESOLUTION; HIGH-FIELD; HUMAN BRAIN; INHOMOGENEITIES; MR ANGIOGRAPHY; MR SCANNERS; MRI AND MRS; RADIO FREQUENCIES; SAFETY ISSUES; SIGNAL TO NOISE; SKELETAL MUSCLE; SPECIFIC ABSORPTION RATE; TECHNICAL DEVELOPMENT; TIME OF FLIGHT; ULTRAHIGH-FIELD MR; VASCULAR;

ACCIDENT PREVENTION; BRAIN; CARTILAGE; DIAGNOSIS; ELECTROMAGNETIC FIELD EFFECTS; HEART; MAGNETIC FIELDS; SODIUM;

RESEARCH;

COLLAGEN FIBER; COLLAGEN TYPE 2; GADOLINIUM; HEMOSIDERIN; PROTEOGLYCAN;

ABSORPTION; ARTICULAR CARTILAGE; BRAIN INJURY; BRAIN METABOLISM; BRAIN METASTASIS; CARTILAGE; CARTILAGE DEGENERATION; CAVERNOUS HEMANGIOMA; CELL MEMBRANE; CEREBELLUM NUCLEUS; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ELECTROMAGNETIC FIELD; EXTRACELLULAR MATRIX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; MAGNETIC FIELD; MAGNETIC RESONANCE ANGIOGRAPHY; MICROANGIOPATHY; MOLECULAR IMAGING; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSTEOARTHRITIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSTERIOR FOSSA; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION; RADIATION DOSE; RADIOFREQUENCY; REVIEW; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; SPIN LABELING; SPINOCEREBELLAR DEGENERATION; STEADY STATE; TRABECULAR BONE;

HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84859646398     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1794     Document Type: Review

References (197)

1. Moser E, Trattnig S. 3.0 Tesla MR systems. Invest. Radiol. 2003; 38(7): 375-376.
2. Robitaille PM, Abduljalil AM, Kangarlu A. Ultra high resolution imaging of the human head at 8 tesla: 2K x 2K for Y2K. J. Comput. Assist. Tomogr. 2000; 24(1): 2-8.
3. Vaughan JT, Garwood M, Collins CM, Liu W, DelaBarre L, Adriany G, Andersen P, Merkle H, Goebel R, Smith MB, Ugurbil K. 7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn. Reson. Med. 2001; 46(1): 24-30.
4. Ugurbil K, Adriany G, Andersen P, Chen W, Garwood M, Gruetter R, Henry PG, Kim SG, Lieu H, Tkac I, Vaughan T, Van De Moortele PF, Yacoub E, Zhu XH. Ultrahigh field magnetic resonance imaging and spectroscopy. Magn. Reson. Imaging 2003; 21(10): 1263-1281.
5. Norris DG. High field human imaging. J. Magn. Reson. Imaging 2003; 18(5): 519-529.
6. 1H NMR spectroscopy of the human brain at 7T. Magn. Reson. Med. 2001; 46(3): 451-456.
7. Yacoub E, Shmuel A, Pfeuffer J, Van De Moortele PF, Adriany G, Andersen P, Vaughan JT, Merkle H, Ugurbil K, Hu X. Imaging brain function in humans at 7 Tesla. Magn. Reson. Med. 2001; 45(4): 588-594.
8. Pfeuffer J, Adriany G, Shmuel A, Yacoub E, Van De Moortele PF, Hu X, Ugurbil K. Perfusion-based high-resolution functional imaging in the human brain at 7 Tesla. Magn. Reson. Med. 2002; 47(5): 903-911.
9. Terpstra M, Ugurbil K, Gruetter R. Direct invivo measurement of human cerebral GABA concentration using MEGA-editing at 7 Tesla. Magn. Reson. Med. 2002; 47(5): 1009-1012.
10. Krug R, Carballido-Gamio J, Banerjee S, Burghardt AJ, Link TM, Majumdar S. Invivo ultra-high-field magnetic resonance imaging of trabecular bone microarchitecture at 7T. J. Magn. Reson. Imaging 2008; 27(4): 854-859.
11. Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn JM, Kraff O, Ladd ME, Forsting M, Wanke I. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. Am. J. Neuroradiol. 2009; 30(4): 699-702.
12. Laule C, Kozlowski P, Leung E, Li DK, Mackay AL, Moore GR. Myelin water imaging of multiple sclerosis at 7T: correlations with histopathology. Neuroimage 2008; 40(4): 1575-1580.
13. Nakada T, Matsuzawa H, Igarashi H, Fujii Y, Kwee IL. Invivo visualization of senile-plaque-like pathology in Alzheimer's disease patients by MR microscopy on a 7T system. J. Neuroimaging 2008; 18(2): 125-129.
14. Yao B, Li TQ, Gelderen P, Shmueli K, de Zwart JA, Duyn JH. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. NeuroImage 2009; 44(4): 1259-1266.
15. Triantafyllou C, Hoge RD, Krueger G, Wiggins CJ, Potthast A, Wiggins GC, Wald LL. Comparison of physiological noise at 1.5T, 3T and 7T and optimization of fMRI acquisition parameters. Neuroimage 2005; 26(1): 243-250.
16. van der Zwaag W, Francis S, Head K, Peters A, Gowland P, Morris P, Bowtell R. fMRI at 1.5, 3 and 7T: characterising BOLD signal changes. Neuroimage 2009; 47(4): 1425-1434.
17. Reichenbach JR, Barth M, Haacke EM, Klarhofer M, Kaiser WA, Moser E. High-resolution MR venography at 3.0 Tesla. J. Comput. Assist. Tomogr. 2000; 24(6): 949-957.
18. Deistung A, Rauscher A, Sedlacik J, Stadler J, Witoszynskyj S, Reichenbach JR. Susceptibility weighted imaging at ultra high magnetic field strengths: theoretical considerations and experimental results. Magn. Reson. Med. 2008; 60(5): 1155-1168.
19. Reichenbach JR, Venkatesan R, Schillinger DJ, Kido DK, Haacke EM. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997; 204(1): 272-277.
20. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to invivo brain iron metabolism? NeuroImage 2011; 54(4): 2789-2807.
21. de Rochefort L, Brown R, Prince MR, Wang Y. Quantitative MR susceptibility mapping using piece-wise constant regularized inversion of the magnetic field. Magn. Reson. Med. 2008; 60(4): 1003-1009.
22. Schweser F, Deistung A, Lehr BW, Reichenbach JR. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med. Phys. 2010; 37(10): 5165-5178.
23. Haacke EM, Tang J, Neelavalli J, Cheng YC. Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J. Magn. Reson. Imaging 2010; 32(3): 663-676.
24. Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. NeuroImage 2011; 55(4): 1645-1656.
25. Jerde TA, Lewis SM, Goerke U, Gourtzelidis P, Tzagarakis C, Lynch J, Moeller S, Van de Moortele PF, Adriany G, Trangle J, Ugurbil K, Georgopoulos AP. Ultra-high field parallel imaging of the superior parietal lobule during mental maze solving. Exp. Brain Res. 2008; 187(4): 551-561.
26. 1H-MRSI of the human brain at 7T with slice-selective adiabatic refocusing pulses. MAGMA 2008; 21(1-2): 95-101.
27. Hussain MS, Stobbe RW, Bhagat YA, Emery D, Butcher KS, Manawadu D, Rizvi N, Maheshwari P, Scozzafava J, Shuaib A, Beaulieu C. Sodium imaging intensity increases with time after human ischemic stroke. Ann. Neurol. 2009; 66(1): 55-62.
28. 23Na MR imaging at 7T after knee matrix-associated autologous chondrocyte transplantation preliminary results. Radiology 2010; 257(1): 175-184.
29. Cady EB. Clinical Magnetic Resonance Spectroscopy. Plenum Press: New York and London; 1990.
30. Moser E. Ultra-high field magnetic resonance: why and when? World J. Radiol. 2010; 2(2): 4.
31. Moser E, Meyerspeer M, Fischmeister FPS, Grabner G, Bauer H, Trattnig S. Windows on the human body-invivo high-field magnetic resonance research and applications in medicine and psychology. Sensors 2010; 10(6): 33.
32. 2O relaxation invivo. Magn. Reson. Med. 2007; 57(2): 308-318.
33. Bogner W, Chmelik M, Schmid AI, Moser E, Trattnig S, Gruber S. Assessment of (31)P relaxation times in the human calf muscle: a comparison between 3T and 7T invivo. Magn. Reson. Med. 2009; 62(3): 574-582.
34. Meyerspeer M, Kemp GJ, Mlynarik V, Krssak M, Szendroedi J, Nowotny P, Roden M, Moser E. Direct noninvasive quantification of lactate and high energy phosphates simultaneously in exercising human skeletal muscle by localized magnetic resonance spectroscopy. Magn. Reson. Med. 2007; 57(4): 654-660.
35. 31P MRS in exercising muscle at ultra-high magnetic field. Magn. Reson. Med. 2010; 65(5): 1207-1215.
36. Ladd ME. High-field-strength magnetic resonance: potential and limits. Top. Magn. Reson. Imaging 2007; 18(2): 139-152.
37. Adriany G, Van de Moortele PF, Wiesinger F, Moeller S, Strupp JP, Andersen P, Snyder C, Zhang X, Chen W, Pruessmann KP, Boesiger P, Vaughan T, Ugurbil K. Transmit and receive transmission line arrays for 7 Tesla parallel imaging. Magn. Reson. Med. 2005; 53(2): 434-445.
38. Wiesinger F, Boesiger P, Pruessmann KP. Electrodynamics and ultimate SNR in parallel MR imaging. Magn. Reson. Med. 2004; 52(2): 376-390.
39. Wiesinger F, Van de Moortele PF, Adriany G, De Zanche N, Ugurbil K, Pruessmann KP. Potential and feasibility of parallel MRI at high field. NMR Biomed. 2006; 19(3): 368-378.
40. Brunner DO, De Zanche N, Frohlich J, Paska J, Pruessmann KP. Travelling-wave nuclear magnetic resonance. Nature 2009; 457(7232): 994-998.
41. Van de Moortele PF, Akgun C, Adriany G, Moeller S, Ritter J, Collins CM, Smith MB, Vaughan JT, Ugurbil K. B(1) destructive interferences and spatial phase patterns at 7T with a head transceiver array coil. Magn. Reson. Med. 2005; 54(6): 1503-1518.
42. Setsompop K, Alagappan V, Zelinski AC, Potthast A, Fontius U, Hebrank F, Schmitt F, Wald LL, Adalsteinsson E. High-flip-angle slice-selective parallel RF transmission with 8 channels at 7T. J. Magn. Reson. 2008; 195(1): 76-84.
43. Katscher U, Bornert P. Parallel RF transmission in MRI. NMR Biomed. 2006; 19(3): 393-400.
44. Katscher U, Bornert P, Leussler C, van den Brink JS. Transmit SENSE. Magn. Reson. Med. 2003; 49(1): 144-150.
45. Heidemann RM, Porter DA, Anwander A, Feiweier T, Heberlein K, Knosche TR, Turner R. Diffusion imaging in humans at 7T using readout-segmented EPI and GRAPPA. Magn. Reson. Med. 2010; 64(1): 9-14.
46. Blamire AM, Rothman DL, Nixon T. Dynamic shim updating: a new approach towards optimized whole brain shimming. Magn. Reson. Med. 1996; 36(1): 159-165.
47. Sengupta S, Welch EB, Zhao Y, Foxall D, Starewicz P, Anderson AW, Gore JC, Avison MJ. Dynamic B(0) shimming at 7T. Magn. Reson. Imaging 2011; 29(4): 483-496.
48. Henning A, Fuchs A, Murdoch JB, Boesiger P. Slice-selective FID acquisition, localized by outer volume suppression (FIDLOVS) for (1)H-MRSI of the human brain at 7T with minimal signal loss. NMR Biomed. 2009; 22(7): 683-696.
49. Hetherington HP, Avdievich NI, Kuznetsov AM, Pan JW. RF shimming for spectroscopic localization in the human brain at 7T. Magn. Reson. Med. 2010; 63(1): 9-19.
50. Avdievich NI, Pan JW, Baehring JM, Spencer DD, Hetherington HP. Short echo spectroscopic imaging of the human brain at 7T using transceiver arrays. Magn. Reson. Med. 2009; 62(1): 17-25.
51. 1H MRSI at 7T using spectrally selective adiabatic inversion recovery. Magn. Reson. Med. 2008; 59(5): 980-988.
52. Xu D, Cunningham CH, Chen AP, Li Y, Kelley DA, Mukherjee P, Pauly JM, Nelson SJ, Vigneron DB. Phased array 3D MR spectroscopic imaging of the brain at 7T. Magn. Reson. Imaging 2008; 26(9): 1201-1206.
53. 1H MR spectroscopic imaging at 7 Tesla using 'spectroscopic missing pulse-SSFP'. Magn. Reson. Med. 2008; 60(5): 1243-1249.
54. Wright AC, Lemdiasov R, Connick TJ, Bhagat YA, Magland JF, Song HK, Toddes SP, Ludwig R, Wehrli FW. Helmholtz-pair transmit coil with integrated receive array for high-resolution MRI of trabecular bone in the distal tibia at 7T. J. Magn. Reson. 2011; 210(1): 113-122.
55. Zelinski AC, Angelone LM, Goyal VK, Bonmassar G, Adalsteinsson E, Wald LL. Specific absorption rate studies of the parallel transmission of inner-volume excitations at 7T. J. Magn. Reson. Imaging 2008; 28(4): 1005-1018.
56. van den Bergen B, van den Berg CA, Klomp DW, Lagendijk JJ. SAR and power implications of different RF shimming strategies in the pelvis for 7T MRI. J. Magn. Reson. Imaging 2009; 30(1): 194-202.
57. Vaughan JT, Snyder CJ, DelaBarre LJ, Bolan PJ, Tian J, Bolinger L, Adriany G, Andersen P, Strupp J, Ugurbil K. Whole-body imaging at 7T: preliminary results. Magn. Reson. Med. 2009; 61(1): 244-248.
58. Chakeres DW, Kangarlu A, Boudoulas H, Young DC. Effect of static magnetic field exposure of up to 8 Tesla on sequential human vital sign measurements. J. Magn. Reson. Imaging 2003; 18(3): 346-352.
59. de Vocht F, Stevens T, Glover P, Sunderland A, Gowland P, Kromhout H. Cognitive effects of head-movements in stray fields generated by a 7 Tesla whole-body MRI magnet. Bioelectromagnetics 2007; 28(4): 247-255.
60. Theysohn JM, Maderwald S, Kraff O, Moenninghoff C, Ladd ME, Ladd SC. Subjective acceptance of 7 Tesla MRI for human imaging. MAGMA 2008; 21(1-2): 63-72.
61. International Electrotechnical Commission (IEC). Medical electrical equipment-Particular requirements for the safety of magnetic resonance equipment for medical diagnosis. IEC 60601-2-33, 3.0 2010-03 edn. International Electrotechnical Commission: Geneva, Switzerland; 2010.
62. International Commission on Non-Ionizing Radiation Protection (ICNIRP). Guidelines on limits of exposure to static magnetic fields. Health Phys. 2009; 96(4): 504-514.
63. International Commission on Non-Ionizing Radiation Protection (ICNIRP). Guidelines for limiting exposure to time-varying electric and magnetic fields (1Hz to 100kHz). Health Phys. 2010; 99(6): 818-836.
64. Moser E, Trattnig S. Institute Spotlight. Diagnostic Imaging Europe 2011; February/March: 16-18.
65. Lupo JM, Banerjee S, Hammond KE, Kelley DA, Xu D, Chang SM, Vigneron DB, Majumdar S, Nelson SJ. GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7T. Magn. Reson. Imaging 2009; 27(4): 480-488.
66. Moenninghoff C, Maderwald S, Theysohn JM, Kraff O, Ladd ME, El Hindy N, van de Nes J, Forsting M, Wanke I. Imaging of adult astrocytic brain tumours with 7T MRI: preliminary results. Eur. Radiol. 2009; 20(3): 704-713.
67. Monninghoff C, Maderwald S, Theysohn JM, Schutt P, Gauler T, Kraff O, Ladd ME, Ladd SC, Wanke I. Imaging of brain metastases of bronchial carcinomas with 7T MRI-initial results. Rofo 2010; 182(9): 764-772.
68. Theysohn JM, Kraff O, Maderwald S, Schlamann MU, de Greiff A, Forsting M, Ladd SC, Ladd ME, Gizewski ER. The human hippocampus at 7T-invivo MRI. Hippocampus 2009; 19(1): 1-7.
69. Thomas BP, Welch EB, Niederhauser BD, Whetsell WO Jr, Anderson AW, Gore JC, Avison MJ, Creasy JL. High-resolution 7T MRI of the human hippocampus invivo. J. Magn. Reson. Imaging 2008; 28(5): 1266-1272.
70. Zijlmans M, de Kort GA, Witkamp TD, Huiskamp GM, Seppenwoolde JH, van Huffelen AC, Leijten FS. 3T versus 1.5T phased-array MRI in the presurgical work-up of patients with partial epilepsy of uncertain focus. J. Magn. Reson. Imaging 2009; 30(2): 256-262.
71. Breyer T, Wanke I, Maderwald S, Woermann FG, Kraff O, Theysohn JM, Ebner A, Forsting M, Ladd ME, Schlamann M. Imaging of patients with hippocampal sclerosis at 7 Tesla: initial results. Acad. Radiol. 2010; 17(4): 421-426.
72. Cho ZH, Han JY, Hwang SI, Kim DS, Kim KN, Kim NB, Kim SJ, Chi JG, Park CW, Kim YB. Quantitative analysis of the hippocampus using images obtained from 7.0T MRI. Neuroimage 2010; 49(3): 2134-2140.
73. Cho ZH, Kim YB, Han JY, Kim NB, Hwang SI, Kim SJ, Cho SJ. Altered T2* relaxation time of the hippocampus in major depressive disorder: implications of ultra-high field magnetic resonance imaging. J. Psychiatr. Res. 2010; 44(14): 881-886.
74. Meyer JS, Quach M, Thornby J, Chowdhury M, Huang J. MRI identifies MCI subtypes: vascular versus neurodegenerative. J. Neurol. Sci. 2005; 229-230: 121-129.
75. Visser F, Zwanenburg JJ, Hoogduin JM, Luijten PR. High-resolution magnetization-prepared 3D-FLAIR imaging at 7.0 Tesla. Magn. Reson. Med. 2010; 64(1): 194-202.
76. Zwanenburg JJ, Hendrikse J, Visser F, Takahara T, Luijten PR. Fluid attenuated inversion recovery (FLAIR) MRI at 7.0 Tesla: comparison with 1.5 and 3.0 Tesla. Eur. Radiol. 2010; 20(4): 915-922.
77. Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, Brown MM, Jager HR. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004; 127(Pt 10): 2265-2275.
78. Derex L, Nighoghossian N, Hermier M, Adeleine P, Philippeau F, Honnorat J, Yilmaz H, Dardel P, Froment JC, Trouillas P. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI. Cerebrovasc. Dis. 2004; 17(2-3): 238-241.
79. Lee SH, Bae HJ, Kwon SJ, Kim H, Kim YH, Yoon BW, Roh JK. Cerebral microbleeds are regionally associated with intracerebral hemorrhage. Neurology 2004; 62(1): 72-76.
80. Theysohn JM, Kraff O, Maderwald S, Barth M, Ladd SC, Forsting M, Ladd ME, Gizewski ER. 7 tesla MRI of microbleeds and white matter lesions as seen in vascular dementia. J. Magn. Reson. Imaging 2011; 33(4): 782-791.
81. Mainero C, Benner T, Radding A, van der Kouwe A, Jensen R, Rosen BR, Kinkel RP. Invivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009; 73(12): 941-948.
82. Metcalf M, Xu D, Okuda DT, Carvajal L, Srinivasan R, Kelley DA, Mukherjee P, Nelson SJ, Vigneron DB, Pelletier D. High-resolution phased-array MRI of the human brain at 7 Tesla: initial experience in multiple sclerosis patients. J. Neuroimaging 2010; 20(2): 141-147.
83. Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Morris PG, Evangelou N. 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J. Magn. Reson. Imaging 2010; 32(4): 971-977.
84. Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions invivo with 7-Tesla MRI. Neurology 2008; 70(22): 2076-2078.
85. Ge Y, Zohrabian VM, Grossman RI. Seven-tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch. Neurol. 2008; 65(6): 812-816.
86. Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Evangelou N, Morris PG. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest. Radiol. 2009; 44(9): 491-494.
87. Hammond KE, Metcalf M, Carvajal L, Okuda DT, Srinivasan R, Vigneron D, Nelson SJ, Pelletier D. Quantitative invivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann. Neurol. 2008; 64(6): 707-713.
88. von Morze C, Xu D, Purcell DD, Hess CP, Mukherjee P, Saloner D, Kelley DA, Vigneron DB. Intracranial time-of-flight MR angiography at 7T with comparison to 3T. J. Magn. Reson. Imaging 2007; 26(4): 900-904.
89. Heverhagen JT, Bourekas E, Sammet S, Knopp MV, Schmalbrock P. Time-of-flight magnetic resonance angiography at 7 Tesla. Invest. Radiol. 2008; 43(8): 568-573.
90. Kang CK, Hong SM, Han JY, Kim KN, Kim SH, Kim YB, Cho ZH. Evaluation of MR angiography at 7.0 Tesla MRI using birdcage radio frequency coils with end caps. Magn. Reson. Med. 2008; 60(2): 330-338.
91. Cho ZH, Kang CK, Han JY, Kim SH, Kim KN, Hong SM, Park CW, Kim YB. Observation of the lenticulostriate arteries in the human brain invivo using 7.0T MR angiography. Stroke 2008; 39(5): 1604-1606.
92. Kang CK, Park CW, Han JY, Kim SH, Park CA, Kim KN, Hong SM, Kim YB, Lee KH, Cho ZH. Imaging and analysis of lenticulostriate arteries using 7.0-Tesla magnetic resonance angiography. Magn. Reson. Med. 2009; 61(1): 136-144.
93. Conijn MM, Hendrikse J, Zwanenburg JJ, Takahara T, Geerlings MI, Mali WP, Luijten PR. Perforating arteries originating from the posterior communicating artery: a 7.0-Tesla MRI study. Eur. Radiol. 2009; 19(12): 2986-2992.
94. Maderwald S, Ladd SC, Gizewski ER, Kraff O, Theysohn JM, Wicklow K, Moenninghoff C, Wanke I, Ladd ME, Quick HH. To TOF or not to TOF: strategies for non-contrast-enhanced intracranial MRA at 7T. MAGMA 2008; 21(1-2): 159-167.
95. Zwanenburg JJ, Hendrikse J, Takahara T, Visser F, Luijten PR. MR angiography of the cerebral perforating arteries with magnetization prepared anatomical reference at 7T: comparison with time-of-flight. J. Magn. Reson. Imaging 2008; 28(6): 1519-1526.
96. Van de Moortele PF, Auerbach EJ, Olman C, Yacoub E, Ugurbil K, Moeller S. T1 weighted brain images at 7 Tesla unbiased for proton density, T2* contrast and RF coil receive B1 sensitivity with simultaneous vessel visualization. Neuroimage 2009; 46(2): 432-446.
97. Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele PF, Gruetter R. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage 2010; 49(2): 1271-1281.
98. Monninghoff C, Maderwald S, Theysohn JM, Kraff O, Ladd SC, Ladd ME, Forsting M, Quick HH, Wanke I. Evaluation of intracranial aneurysms with 7T versus 1.5T time-of-flight MR angiography-initial experience. Rofo 2009; 181(1): 16-23.
99. Monninghoff C, Maderwald S, Wanke I. Pre-interventional assessment of a vertebrobasilar aneurysm with 7 tesla time-of-flight MR angiography. Rofo 2009; 181(3): 266-268.
100. Schlamann M, Maderwald S, Becker W, Kraff O, Theysohn JM, Mueller O, Sure U, Wanke I, Ladd ME, Forsting M, Schaefer L, Gizewski ER. Cerebral cavernous hemangiomas at 7 Tesla: initial experience. Acad. Radiol. 2010; 17(1): 3-6.
101. Dammann P, Barth M, Zhu Y, Maderwald S, Schlamann M, Ladd ME, Sure U. Susceptibility weighted magnetic resonance imaging of cerebral cavernous malformations: prospects, drawbacks, and first experience at ultra-high field strength (7-Tesla) magnetic resonance imaging. Neurosurg. Focus 2010; 29(3): E5.
102. Brandauer B, Hermsdorfer J, Beck A, Aurich V, Gizewski ER, Marquardt C, Timmann D. Impairments of prehension kinematics and grasping forces in patients with cerebellar degeneration and the relationship to cerebellar atrophy. Clin. Neurophysiol. 2008; 119(11): 2528-2537.
103. Schulz JB, Borkert J, Wolf S, Schmitz-Hubsch T, Rakowicz M, Mariotti C, Schoels L, Timmann D, van de Warrenburg B, Durr A, Pandolfo M, Kang JS, Mandly AG, Nagele T, Grisoli M, Boguslawska R, Bauer P, Klockgether T, Hauser TK. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage 2010; 49(1): 158-168.
104. Kuper M, Thurling M, Maderwald S, Ladd ME, Timmann D. Structural and functional magnetic resonance imaging of the human cerebellar nuclei. Cerebellum 2010; DOI: 10.1007/s12311-010-0194-5 [Epub ahead of print].
105. Berg D, Youdim MB. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 2006; 17(1): 5-17.
106. Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM. Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics 2009; 29(5): 1433-1449.
107. Marques JP, Maddage R, Mlynarik V, Gruetter R. On the origin of the MR image phase contrast: an invivo MR microscopy study of the rat brain at 14.1T. Neuroimage 2009; 46(2): 345-352.
108. Koeppen AH. The pathogenesis of spinocerebellar ataxia. Cerebellum 2005; 4(1): 62-73.
109. Windischberger C, Fischmeister FP, Schopf V, Sladky R, Moser E. Functional magnetic resonance imaging with ultra-high fields. Radiologe 2010; 50(2): 144-151.
110. Poser BA, Norris DG. Investigating the benefits of multi-echo EPI for fMRI at 7T. Neuroimage 2009; 45(4): 1162-1172.
111. Beisteiner R, Robinson S, Wurnig M, Hilbert M, Merksa K, Rath J, Hollinger I, Klinger N, Marosi C, Trattnig S, Geissler A. Clinical fMRI: evidence for a 7T benefit over 3T. Neuroimage 2011; 57(3): 1015-1021.
112. Timmann D, Daum I. Cerebellar contributions to cognitive functions: a progress report after two decades of research. Cerebellum 2007; 6(3): 159-162.
113. Strick PL, Dum RP, Fiez JA. Cerebellum and nonmotor function. Annu. Rev. Neurosci. 2009; 32: 413-434.
114. Dimitrova A, de Greiff A, Schoch B, Gerwig M, Frings M, Gizewski ER, Timmann D. Activation of cerebellar nuclei comparing finger, foot and tongue movements as revealed by fMRI. Brain Res. Bull. 2006; 71(1-3): 233-241.
115. Habas C. Functional imaging of the deep cerebellar nuclei: a review. Cerebellum 2010; 9(1): 22-28.
116. Di Ieva A, Tschabitscher M, Galzio RJ, Grabner G, Kronnerwetter C, Widhalm G, Matula C, Trattnig S. The veins of the nucleus dentatus: anatomical and radiological findings. Neuroimage 2011; 54(1): 74-79.
117. Logothetis NK, Wandell BA. Interpreting the BOLD signal. Annu. Rev. Physiol. 2004; 66: 735-769.
118. Logothetis N, Merkle H, Augath M, Trinath T, Ugurbil K. Ultra high-resolution fMRI in monkeys with implanted RF coils. Neuron 2002; 35(2): 227-242.
119. Küper M, Dimitrova A, Thürling M, Maderwald S, Roths J, Elles HG, Gizewski ER, Ladd ME, Diedrichsen J, Timmann D. Evidence for a motor and a non-motor domain in the human dentate nucleus-an fMRI study. Neuroimage 2011; 54(4): 2612-2622.
120. Habas C, Guillevin R, Abanou A. Invivo structural and functional imaging of the human rubral and inferior olivary nuclei: a mini-review. Cerebellum 2010; 9(2): 167-173. Review
121. Fillippi M (ed). Part II: FMRI Application to Measure Brain Function. In FMRI Techniques and Protocols, Walz W series editor (ed). Humana Press, Springer: 2009; 285-569.
122. Mlynarik V, Gruber S, Moser E. Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla. NMR Biomed. 2001; 14(5): 325-331.
123. Gonen O, Gruber S, Li BS, Mlynarik V, Moser E. Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0T: signal-to-noise ratio and resolution comparison. Am. J. Neuroradiol. 2001; 22(9): 1727-1731.
124. Gruber S, Mlynarik V, Moser E. High-resolution 3D proton spectroscopic imaging of the human brain at 3T: SNR issues and application for anatomy-matched voxel sizes. Magn. Reson. Med. 2003; 49(2): 299-306.
125. Bogner W, Gruber S, Doelken M, Stadlbauer A, Ganslandt O, Boettcher U, Trattnig S, Doerfler A, Stefan H, Hammen T. Invivo quantification of intracerebral GABA by single-voxel (1)H-MRS-how reproducible are the results? Eur. J. Radiol. 2010; 73(3): 526-531.
126. Mekle R, Mlynarik V, Gambarota G, Hergt M, Krueger G, Gruetter R. MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T. Magn. Reson. Med. 2009; 61(6): 1279-1285.
127. 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs. 7T. Magn. Reson. Med. 2009; 62(4): 868-879.
128. Carlsson A, Ljungberg M, Starck G, Forssell-Aronsson E. Degraded water suppression in small volume (1)H MRS due to localised shimming. MAGMA 2011; 24(2): 97-107.
129. Ganslandt O, Stadlbauer A, Fahlbusch R, Kamada K, Buslei R, Blumcke I, Moser E, Nimsky C. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density. Neurosurgery 2005; 56(2 Suppl): 291-298; discussion 291-298.
130. Boer VO, Siero JC, Hoogduin H, van Gorp JS, Luijten PR, Klomp DW. High-field MRS of the human brain at short TE and TR. NMR Biomed. 2011; 24(9): 1081-1088.
131. Snyder J, Wilman A. Field strength dependence of PRESS timings for simultaneous detection of glutamate and glutamine from 1.5 to 7T. J. Magn. Reson. 2010; 203(1): 66-72.
132. Pan JW, Avdievich N, Hetherington HP. J-refocused coherence transfer spectroscopic imaging at 7T in human brain. Magn. Reson. Med. 2010; 64(5): 1237-1246.
133. 1H MRS in human brain at 7T. MAGMA 2009; 22(1): 1-4.
134. Bogner W, Gruber S, Trattnig S, Chmelik M. High-resolution mapping of human brain metabolites by proton FID-MRSI at 7T. NMR Biomed. 2011; in press.
135. Hetherington H. Novel approaches to imaging epilepsy by MRI. Future Neurol. 2009; 4(3): 295-304.
136. Bogner W, Chmelik M, Andronesi OC, Sorensen AG, Trattnig S, Gruber S. Invivo (31) P spectroscopy by fully adiabatic extended image selected invivo spectroscopy: a comparison between 3T and 7T. Magn. Reson. Med. 2011; 66(4): 923-930.
137. Stephenson MC, Gunner F, Napolitano A, Greenhaff PL, Macdonald IA, Saeed N, Vennart W, Francis ST, Morris PG. Applications of multi-nuclear magnetic resonance spectroscopy at 7T. World J. Radiol. 2011; 3(4): 105-113.
138. Krug R, Stehling C, Kelley DA, Majumdar S, Link TM. Imaging of the musculoskeletal system invivo using ultra-high field magnetic resonance at 7T. Invest. Radiol. 2009; 44(9): 613-618.
139. Regatte RR, Schweitzer ME. Ultra-high-field MRI of the musculoskeletal system at 7.0T. J. Magn. Reson. Imaging 2007; 25(2): 262-269.
140. Friedrich KM, Chang G, Vieira RL, Wang L, Wiggins GC, Schweitzer ME, Regatte RR. Invivo 7.0-tesla magnetic resonance imaging of the wrist and hand: technical aspects and applications. Semin. Musculoskelet. Radiol. 2009; 13(1): 74-84.
141. Goldstein SA, Goulet R, McCubbrey D. Measurement and significance of three-dimensional architecture to the mechanical integrity of trabecular bone. Calcif. Tissue Int. 1993; 53(Suppl 1): S127-132; discussion S132-133.
142. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM. The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif. Tissue Int. 1985; 37(6): 594-597.
143. Borah B, Dufresne TE, Chmielewski PA, Gross GJ, Prenger MC, Phipps RJ. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J. Bone Miner. Res. 2002; 17(7): 1139-1147.
144. Ding M, Odgaard A, Linde F, Hvid I. Age-related variations in the microstructure of human tibial cancellous bone. J. Orthop. Res. 2002; 20(3): 615-621.
145. Krug R, Carballido-Gamio J, Banerjee S, Stahl R, Carvajal L, Xu D, Vigneron D, Kelley DA, Link TM, Majumdar S. Invivo bone and cartilage MRI using fully-balanced steady-state free-precession at 7 tesla. Magn. Reson. Med. 2007; 58(6): 1294-1298.
146. Hopkins JA, Wehrli FW. Magnetic susceptibility measurement of insoluble solids by NMR: magnetic susceptibility of bone. Magn. Reson. Med. 1997; 37(4): 494-500.
147. Chang G, Regatte RR, Schweitzer ME. Olympic fencers: adaptations in cortical and trabecular bone determined by quantitative computed tomography. Osteoporos. Int. 2009; 20(5): 779-785.
148. Stahl R, Krug R, Kelley DA, Zuo J, Ma CB, Majumdar S, Link TM. Assessment of cartilage-dedicated sequences at ultra-high-field MRI: comparison of imaging performance and diagnostic confidence between 3.0 and 7.0T with respect to osteoarthritis-induced changes at the knee joint. Skeletal Radiol. 2009; 38(8): 771-783.
149. Kraff O, Theysohn JM, Maderwald S, Saylor C, Ladd SC, Ladd ME, Barkhausen J. MRI of the knee at 7.0 Tesla. Rofo 2007; 179(12): 1231-1235.
150. Mosher TJ, Dardzinski BJ. Cartilage MRI T2 relaxation time mapping: overview and applications. Semin. Musculoskelet. Radiol. 2004; 8(4): 355-368.
151. Smith HE, Mosher TJ, Dardzinski BJ, Collins BG, Collins CM, Yang QX, Schmithorst VJ, Smith MB. Spatial variation in cartilage T2 of the knee. J. Magn. Reson. Imaging 2001; 14(1): 50-55.
152. Welsch GH, Mamisch TC, Hughes T, Zilkens C, Quirbach S, Scheffler K, Kraff O, Schweitzer ME, Szomolanyi P, Trattnig S. Invivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage. Invest. Radiol. 2008; 43(9): 619-626.
153. Pakin SK, Cavalcanti C, La Rocca R, Schweitzer ME, Regatte RR. Ultra-high-field MRI of knee joint at 7.0T: preliminary experience. Acad. Radiol. 2006; 13(9): 1135-1142.
154. Murphy BJ. Evaluation of grades 3 and 4 chondromalacia of the knee using T2*-weighted 3D gradient-echo articular cartilage imaging. Skeletal Radiol. 2001; 30(6): 305-311.
155. Hughes T, Welsch GH, Trattnig S, Brandi L, Domayer S, Mamisch TC. T2-star relaxation as a means to differentiatie cartilage repair tissue after microfracturing therapy. Int. Soc. Magn. Reson. Med. 2007; 15: 183.
156. Wietek B, Martirosian P, Machann J, Mueller-Horvath C, Claussen CD, Schick F. T2 and T2* mapping of the human femoral-tibial cartilage at 1.5 and 3 Tesla. Int. Soc. Magn. Reson. Med. 2007; 15: 516.
157. Mankin HJ. Biochemical and metabolic aspects of osteoarthritis. Orthoped. Clin. N. Am. 1971; 2(1): 19-31.
158. Roughley PJ, Lee ER. Cartilage proteoglycans: structure and potential functions. Microsc. Res. Tech. 1994; 28(5): 385-397.
159. Lohmander LS. Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease. J. Anat. 1994; 184(Pt 3): 477-492.
160. Grushko G, Schneiderman R, Maroudas A. Some biochemical and biophysical parameters for the study of the pathogenesis of osteoarthritis: a comparison between the processes of ageing and degeneration in human hip cartilage. Connect. Tissue Res. 1989; 19(2-4): 149-176.
161. Maroudas A, Muir H, Wingham J. The correlation of fixed negative charge with glycosaminoglycan content of human articular cartilage. Biochim. Biophys. Acta 1969; 177(3): 492-500.
162. Borthakur A, Shapiro EM, Beers J, Kudchodkar S, Kneeland JB, Reddy R. Sensitivity of MRI to proteoglycan depletion in cartilage: comparison of sodium and proton MRI. Osteoarthr. Cartil. 2000; 8(4): 288-293.
163. 23Na MRI accurately measures fixed charge density in articular cartilage. Magn. Reson. Med. 2002; 47(2): 284-291.
164. Borthakur A, Shapiro EM, Akella SV, Gougoutas A, Kneeland JB, Reddy R. Quantifying sodium in the human wrist invivo by using MR imaging. Radiology 2002; 224(2): 598-602.
165. Burstein D, Velyvis J, Scott KT, Stock KW, Kim YJ, Jaramillo D, Boutin RD, Gray ML. Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn. Reson. Med. 2001; 45(1): 36-41.
166. Hoult DI, Chen CN, Sank VJ. The field dependence of NMR imaging. II. Arguments concerning an optimal field strength. Magn. Reson. Med. 1986; 3(5): 730-746.
167. Chen CN, Sank VJ, Cohen SM, Hoult DI. The field dependence of NMR imaging. I. Laboratory assessment of signal-to-noise ratio and power deposition. Magn. Reson. Med. 1986; 3(5): 722-729.
168. Snyder CJ, DelaBarre L, Metzger GJ, van de Moortele PF, Akgun C, Ugurbil K, Vaughan JT. Initial results of cardiac imaging at 7 Tesla. Magn. Reson. Med. 2009; 61(3): 517-524.
169. van den Bergen B, Van den Berg CA, Bartels LW, Lagendijk JJ. 7T body MRI: B1 shimming with simultaneous SAR reduction. Phys. Med. Biol. 2007; 52(17): 5429-5441.
170. Orzada S, Maderwald S, Poser BA, Bitz AK, Quick HH, Ladd ME. RF excitation using time interleaved acquisition of modes (TIAMO) to address B1 inhomogeneity in high-field MRI. Magn. Reson. Med. 2010; 64(2): 327-333.
171. Orzada S, Quick H, Ladd M, Bahr A, Bolz T, Yazdanbakhsh P, Solbach K, Bitz A. A flexible 8-channel transmit/receive body coil for 7T human imaging. Proceedings of the 17th Annual Meeting ISMRM, Honolulu, HI, USA, 2009; 2999.
172. Orzada S, Maderwald S, Kraff O, Brote I, Ladd ME, Solbach K, Yazdanbakhsh P, Bahr A, Fautz HP, Bitz A. 16-channel Tx/Rx body coil for RF shimming with selected Cp modes at 7T. Proceedings of the 18th Annual Meeting ISMRM, Stockholm, Sweden, 2010; 50.
173. Umutlu L, Bitz AK, Maderwald S, Orzada S, Kinner S, Kraff O, Brote I, Ladd SC, Antoch G, Ladd ME, Quick HH, Lauenstein TC. 7T liver MRI in humans: initial results. Proceedings of the 18th Annual Meeting ISMRM, Stockholm, Sweden, 2010; 2624.
174. Umutlu L, Kraff O, Orzada S, Fischer A, Kinner S, Maderwald S, Antoch G, Quick HH, Forsting M, Ladd ME, Lauenstein TC. Dynamic contrast-enhanced renal MRI at 7 Tesla: preliminary results. Invest. Radiol. 2011; 46(7): 425-433.
175. Umutlu L, Orzada S, Kinner S, Maderwald S, Brote I, Bitz AK, Kraff O, Ladd SC, Antoch G, Ladd ME, Quick HH, Lauenstein TC. Renal imaging at 7 Tesla: preliminary results. Eur. Radiol. 2011; 21(4): 841-849.
176. Darwish T, Wood B. Nephrogenic systemic fibrosis: what internists need to know. Mo. Med. 2009; 106(5): 373-376.
177. Grinstead JW, Rooney W, Laub G. The origins of bright blood MPRAGE at 7 Tesla and a simultaneous method for T1 imaging and non-contrast MRA. Proceedings of the 18th Annual Meeting ISMRM, Stockholm, Sweden, 2010; 1429.
178. Niendorf T, Sodickson DK, Krombach GA, Schulz-Menger J. Toward cardiovascular MRI at 7T: clinical needs, technical solutions and research promises. Eur. Radiol. 2010; 20(12): 2806-2816.
179. Brandts A, Westenberg JJ, Versluis MJ, Kroft LJ, Smith NB, Webb AG, de Roos A. Quantitative assessment of left ventricular function in humans at 7T. Magn. Reson. Med. 2010; 64(5): 1471-1477.
180. von Knobelsdorff-Brenkenhoff F, Frauenrath T, Prothmann M, Dieringer MA, Hezel F, Renz W, Kretschel K, Niendorf T, Schulz-Menger J. Cardiac chamber quantification using magnetic resonance imaging at 7 Tesla-a pilot study. Eur. Radiol. 2010; 20(12): 2844-2852.
181. van Elderen SG, Versluis MJ, Webb AG, Westenberg JJ, Doornbos J, Smith NB, de Roos A, Stuber M. Initial results on invivo human coronary MR angiography at 7T. Magn. Reson. Med. 2009; 62(6): 1379-1384.
182. van Elderen SG, Versluis MJ, Westenberg JJ, Agarwal H, Smith NB, Stuber M, de Roos A, Webb AG. Right coronary MR angiography at 7T: a direct quantitative and qualitative comparison with 3T in young healthy volunteers. Radiology 2010; 257(1): 254-259.
183. Abi-Abdallah D, Robin V, Drochon A, Fokapu O. Alterations in human ECG due to the MagnetoHydroDynamic effect: a method for accurate R peak detection in the presence of high MHD artifacts. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007; 2007: 1842-1845.
184. Frauenrath T, Hezel F, Heinrichs U, Kozerke S, Utting JF, Kob M, Butenweg C, Boesiger P, Niendorf T. Feasibility of cardiac gating free of interference with electro-magnetic fields at 1.5 Tesla, 3.0 Tesla and 7.0 Tesla using an MR-stethoscope. Invest. Radiol. 2009; 44(9): 539-547.
185. Frauenrath T, Hezel F, Renz W, d'Orth Tde G, Dieringer M, von Knobelsdorff-Brenkenhoff F, Prothmann M, Menger JS, Niendorf T. Acoustic cardiac triggering: a practical solution for synchronization and gating of cardiovascular magnetic resonance at 7 Tesla. J. Cardiovasc. Magn. Reson. 2010; 12: 67.
186. Wu B, Wang C, Krug R, Kelley DA, Xu D, Pang Y, Banerjee S, Vigneron DB, Nelson SJ, Majumdar S, Zhang X. 7T human spine imaging arrays with adjustable inductive decoupling. IEEE Trans. Biomed. Eng. 2010; 57(2): 397-403.
187. Kraff O, Bitz AK, Kruszona S, Orzada S, Schaefer LC, Theysohn JM, Maderwald S, Ladd ME, Quick HH. An eight-channel phased array RF coil for spine MR imaging at 7T. Invest. Radiol. 2009; 44(11): 734-740.
188. Vossen M, Teeuwisse W, Reijnierse M, Collins CM, Smith NB, Webb AG. A radiofrequency coil configuration for imaging the human vertebral column at 7T. J. Magn. Reson. 2011; 208(2): 291-297.
189. Metzger GJ, Snyder C, Akgun C, Vaughan T, Ugurbil K, Van de Moortele PF. Local B1+ shimming for prostate imaging with transceiver arrays at 7T based on subject-dependent transmit phase measurements. Magn. Reson. Med. 2008; 59(2): 396-409.
190. Klomp DW, Bitz AK, Heerschap A, Scheenen TW. Proton spectroscopic imaging of the human prostate at 7T. NMR Biomed. 2009; 22(5): 495-501.
191. Klomp DW, Scheenen TW, Arteaga CS, van Asten J, Boer VO, Luijten PR. Detection of fully refocused polyamine spins in prostate cancer at 7T. NMR Biomed. 2011; 24(3): 299-306.
192. Metzger GJ, van de Moortele PF, Akgun C, Snyder CJ, Moeller S, Strupp J, Andersen P, Shrivastava D, Vaughan T, Ugurbil K, Adriany G. Performance of external and internal coil configurations for prostate investigations at 7T. Magn. Reson. Med. 2010; 64(6): 1625-1639.
193. van den Bergen B, Klomp DW, Raaijmakers AJ, de Castro CA, Boer VO, Kroeze H, Luijten PR, Lagendijk JJ, van den Berg CA. Uniform prostate imaging and spectroscopy at 7T: comparison between a microstrip array and an endorectal coil. NMR Biomed. 2011; 24(4): 358-365.
194. Hecht EM, Lee RF, Taouli B, Sodickson DK. Perspectives on body MR imaging at ultrahigh field. Magn. Reson. Imaging Clin. N. Am. 2007; 15(3): 449-465, viii.
195. Umutlu L, Maderwald S, Kraff O, Theysohn JM, Kuemmel S, Hauth EA, Forsting M, Antoch G, Ladd ME, Quick HH, Lauenstein TC. Dynamic contrast-enhanced breast MRI at 7 Tesla utilizing a single-loop coil: a feasibility trial. Acad. Radiol. 2010; 17(8): 1050-1056.
196. 1H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy. Invest. Radiol. 2011; 46(6): 370-376.
197. Klomp DW, van de Bank BL, Raaijmakers A, Korteweg MA, Possanzini C, Boer VO, van de Berg CA, van de Bosch MA, Luijten PR. (31) P MRSI and (1) H MRS at 7T: initial results in human breast cancer. NMR Biomed. 2011; DOI: 10.1002/nbm.1696. [Epub ahead of print].